Powder Pharms patents expiration
1. Zingo patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8540665 | POWDER PHARMS | Particle cassettes and processes therefor |
Oct, 2029
(6 years from now) | |
| US9358338 | POWDER PHARMS | Particle cassettes and processes therefor |
Apr, 2035
(11 years from now) | |
| US9370622 | POWDER PHARMS | Devices and methods for delivering particles |
Sep, 2035
(12 years from now) | |
Drugs and Companies using LIDOCAINE HYDROCHLORIDE ingredient
Market Authorisation Date: 16 August, 2007
Treatment: Zingo intradermal injection system is a drug delivery system that is capable of delivering fine dry powdered lidocaine hydrochloride monohydrate for local anesthetic action; Zingo is a powder intrader...
Dosage: SYSTEM;INTRADERMAL
More Information on Dosage
ZINGO family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic